An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
Clinical trial NCT03532542 · TERMINATED
Trial details
- NCT number
- NCT03532542
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-02
- Primary completion
- 2023-07-26
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.